Glenmark fined $30 million by DOJ to resolve drug price-fixing charges
The U.S. Department of Justice, Division of Antitrust (DOJ) has postponed prosecution agreements resolving criminal antitrust charges against Teva Pharmaceuticals USA, Inc. and Glenmark Pharmaceuticals Inc., USA. On that note, Glenmark Pharmaceuticals has reached an agreement with the DOJ to resolve all legal proceedings related to former employees’ past valuations related to the generic drug …
Glenmark fined $30 million by DOJ to resolve drug price-fixing charges Read More »